GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on ...
The AstraZeneca office building in Brussels, Friday, Jan. 29, 2021. Amid a dispute over expected shortfalls, the European Union is looking at legal ways to guarantee the delivery of all the COVID-19 ...
As the battle between new respiratory syncytial virus (RSV) vaccines heats up, GSK is “delighted” with the progress it's made ...
Parents have been eagerly awaiting the new immunization, which clinical trials found to be 75% effective at preventing RSV ...
US health authorities on Thursday approved the world's first vaccine for chikungunya, a virus spread by infected mosquitoes that the Food and Drug Administration called "an emerging global health ...
The Food and Drug Adminstration (FDA) approved the first vaccine for the mosquito-born illness chikungunya on Thursday, a key step in fighting the dangerous virus. Chikungunya virus infects more ...
A first of its kind vaccine has been approved by the FDA to prevent infections with the chikungunya virus. The virus is most prevalent in semi-tropical and tropical areas, such as Central and ...
NEW YORK/LONDON (Reuters) -GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory ...
US health authorities on Thursday approved the world's first vaccine for chikungunya, a virus spread by infected mosquitoes that the Food and Drug Administration called "an emerging global health ...
The US Food and Drug Administration said Thursday that it has approved the first vaccine to prevent disease caused by the chikungunya virus. Chikungunya, a mosquito-borne disease whose name in the ...
Nov. 10, 2023 -- The FDA on Thursday approved the first vaccine for the chikungunya virus, which is transmitted to humans through mosquito bites. The vaccine, called Ixchiq and produced by Valneva ...
